Clinical Trial Update: I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update: Irbesartan in adults with mild to moderate hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 4 | Status: COMPLETED